What’s a Safer and Cheaper Way to Lose Weight Than GLP-1 Drugs
Nutrition Facts with Dr. Greger
Michael Greger, M.D. FACLM
4.8 • 3.7K Ratings
🗓️ 21 August 2025
⏱️ 13 minutes
🧾️ Download transcript
Summary
Tackling the root cause of obesity
This episode features audio from Obesity: Is a GLP-1 Deficiency Its Cause, and How to Treat It Without Ozempic and Other Drugs
Visit the video page for all sources and doctor’s notes related to this podcast.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Have you ever wondered if there are more natural ways to lower your high blood pressure, |
| 0:05.5 | guard against Alzheimer's, lose weight, feel better? |
| 0:08.4 | Well, it turns out there is. |
| 0:11.9 | Welcome to the Nutrition Facts podcast. |
| 0:14.5 | I'm your host, Dr. Michael Greger. |
| 0:16.5 | Today we have the final episode in our series on OZembek, and we ask, |
| 0:21.0 | what's a safer and cheaper way to lose weight than GOP1 drugs? |
| 0:26.6 | Can we drug our way out of the obesity crisis? |
| 0:30.7 | Are these GOP1 drugs the answer to the obesity epidemic? |
| 0:34.1 | The head of the European Association for the study of obesity was pretty bullish, |
| 0:38.1 | conveniently failing to disclose that his group had received millions of dollars from the drug maker. |
| 0:44.2 | But doesn't getting a tiny weekly injection sound far easier than getting all sweaty in the gym? |
| 0:50.6 | Do these game-changing new medications make lifestyle-based treatment of obesity obsolete? |
| 0:57.0 | Let's ask those paid by the two main GLP-1 drug makers, which now have a combined net worth |
| 1:02.4 | greater than a trillion dollars. |
| 1:04.9 | The World Obesity Federation, which evidently just got a million dollars from the Ozemic |
| 1:09.4 | company, published a consensus |
| 1:11.3 | statement in one of its journals favoring the definition of obesity as a disease. |
| 1:16.7 | This designation may not benefit patients, but it will benefit doctors and drug companies |
| 1:21.4 | when health insurance and clinical guidelines promote treatment with drugs and surgery. |
| 1:25.7 | A concern is that labeling obesity as a disease |
| 1:28.6 | risks reducing our autonomy, disempowering and robbing us with the intrinsic motivation |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Michael Greger, M.D. FACLM, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Michael Greger, M.D. FACLM and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

